Rutgers Begins Recruiting Participants for Johnson & Johnson Phase 3 COVID-19 Vaccine Clinical Trial
Rutgers University-New BrunswickRutgers University is a clinical trial site for the Janssen Pharmaceutical Companies of Johnson & Johnson’s phase 3 clinical research study to evaluate the safety and efficacy of Janssen’s COVID-19 vaccine candidate.